Page 7 - Briefing Document News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The UK's drug regulator rejected Janssen's esketamine nasal spray. Why did the US FDA approve it?

Global Telco Webtel.mobi’s Briefing Document to International Consultancy Frost & Sullivan for Valuation of its TUV Digital Currency / CBDC-equivalents...

The FDA has rejected Reata Pharmaceuticals’ new drug application (NDA) for bardoxolone methyl (“bardoxolone”) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome.

Louth County Council is seeking to purchase new units for social housing through turnkey developments in County Louth with particular focus on the towns of Dund...

They have left, yes. they feel that they are prepared for the legal battles and challenges. this is something months ago the president said he was hesitant to do this. now this is the only thing that will move some people off the sidelines. >> monica, thank you. let me bring in dr. peter otez. i'm going to put up here just various quotes from some red flags and an fda briefing document about the johnson & johnson booster in particular. there's a lot of booster confusion this morning and this afternoon. data sets were not submitted in a sufficient time to verify. the fda has not independently v...